Core Viewpoint - Kestra Medical Technologies, Ltd. is actively engaging with investors through participation in key healthcare conferences in 2025, showcasing its commitment to advancing its wearable medical devices and digital healthcare solutions [1][2]. Group 1: Upcoming Investor Conferences - Kestra Medical Technologies will participate in the BofA Securities 2025 Health Care Conference on May 14, 2025, at 6:40 p.m. ET [1]. - The company is also scheduled for the Goldman Sachs 46th Annual Global Healthcare Conference on June 11, 2025, at 8:00 a.m. ET [1]. - Live webcasts and replays of the presentations will be available on the company's investor relations website [1]. Group 2: Company Overview - Kestra Medical Technologies is a commercial-stage company focused on wearable medical devices and digital healthcare [2]. - The company aims to transform patient outcomes in cardiovascular disease through intuitive, intelligent, and connected monitoring and therapeutic intervention technologies [2]. - More information about the company can be found on its official website [2].

Company Overview - Penumbra, Inc. is the world's leading thrombectomy company focused on developing innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism, and acute limb ischemia [2] - The company's portfolio includes computer assisted vacuum thrombectomy (CAVT), aimed at removing blood clots efficiently and safely [2] - Penumbra supports healthcare providers in over 100 countries, working to improve patient outcomes and quality of life [2] Upcoming Event - Penumbra's management team is scheduled to present at the BofA Securities 2025 Health Care Conference on May 13, 2025, at 6:00 PM ET [1] - A webcast of the presentation will be available on the company's website for at least two weeks following the event [1]